secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K/A
Filed at:   2026-06-24T20:19:20+00:00
Accession:  0001104659-26-077313
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Armata Pharmaceuticals appoints Dr. Daniel Gilmer to Nominating and Corporate Governance Committee
--------------------------------------------------------------------------------

- Dr. Daniel Gilmer appointed to the Nominating and Corporate Governance Committee effective June 24, 2026.
- Committee cash retainer set at $5,000, pro-rated from effective date.
- Amendment to April 24, 2026 8-K that reported his board appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465926077313/0001104659-26-077313-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465926077313/tm2618503d2_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-077313

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer